Oncocyte Corp Annual Operating Income (Loss) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Oncocyte Corp quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2023.
  • Oncocyte Corp Operating Income (Loss) for the quarter ending September 30, 2024 was -$13.5M, a 108% decline year-over-year.
  • Oncocyte Corp Operating Income (Loss) for the twelve months ending September 30, 2024 was -$43.6M, a 112% decline year-over-year.
  • Oncocyte Corp annual Operating Income (Loss) for 2023 was -$25.1M, a 39.7% decline from 2022.
  • Oncocyte Corp annual Operating Income (Loss) for 2022 was -$18M, a 66.5% increase from 2021.
  • Oncocyte Corp annual Operating Income (Loss) for 2021 was -$53.7M, a 80.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$25.1M -$7.14M -39.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-16
2022 -$18M +$35.7M +66.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-16
2021 -$53.7M -$24M -80.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-12
2020 -$29.7M -$7.47M -33.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2019 -$22.2M -$7.04M -46.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-19
2018 -$15.2M +$3.65M +19.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-26
2017 -$18.8M -$7.71M -69.2% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 -$11.1M -$2.42M -27.8% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 -$8.72M -$3.75M -75.3% Jan 1, 2015 Dec 31, 2015 10-K 2018-04-02
2014 -$4.97M Jan 1, 2014 Dec 31, 2014 10-K 2017-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.